ÂÜÀòÂÒÂ×

Michele Marzola has a long history of work experience. In 2006, they founded and served as Chief Executive Officer of Digital Networks PLC. In 2008, they invested in Rcapoint SpA, and in 2009 they became an Investor for IAG - Italian Angels for Growth and Founder and Chief Executive Officer of Surgica Robotica SpA and Chairman of the Board of XSurgical Inc. In 2015, they acted as Lead Investor for Green Bone Ortho srl. In 2016, they became Co-Founder and Chief Executive Officer of Interceptin srl. In 2019, they were Director and Lead Investor for ReJoint, as well as Director and Lead Investor for Sooma Medical. Finally, in 2021, they became Director and Lead Investor for PEP-Therapy.

Michele Marzola received their Doctorate in Mechanical Engineering from the University of Bologna between 1977 and 1982. Michele then went on to receive their Master in Business Administration from the Columbia Graduate School of Business in New York between 1982 and 1984.